Cipla
Dipesh Patel serves as the Market Access Manager at Cipla since March 2024, following a role as Healthcare Partnership Manager at Thornton & Ross from November 2023 to March 2024. Previously, Dipesh worked at GSK as a Severe Asthma Hospital Account Manager, focusing on building and redesigning service pathways and fostering advocacy with key opinion leaders and stakeholders. In a prior position at ALK, Dipesh held full accountability for driving product portfolio growth within NHS and private accounts, establishing relationships with physicians and prescribers in allergy clinics. Dipesh's experience also includes various roles at Teva Pharmaceuticals, Grünenthal Group, Actavis plc, MSD, Boehringer Ingelheim, and Ashfield, covering areas such as territory management, education, and sales in respiratory care, diabetes, and generics.
This person is not in any offices
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.